PortfoliosLab logoPortfoliosLab logo
WDNA vs. NTSX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

WDNA vs. NTSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WisdomTree BioRevolution Fund (WDNA) and WisdomTree U.S. Efficient Core Fund (NTSX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, WDNA achieves a 8.96% return, which is significantly lower than NTSX's 9.50% return.


WDNA

1D
2.94%
1M
2.56%
YTD
8.96%
6M
10.44%
1Y
50.50%
3Y*
3.54%
5Y*
-4.78%
10Y*

NTSX

1D
0.81%
1M
4.30%
YTD
9.50%
6M
8.89%
1Y
25.65%
3Y*
19.75%
5Y*
9.87%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

WDNA vs. NTSX - Yearly Performance Comparison


2026 (YTD)20252024202320222021
WDNA
WisdomTree BioRevolution Fund
8.96%22.68%-14.18%-2.07%-26.29%-5.27%
NTSX
WisdomTree U.S. Efficient Core Fund
9.50%18.82%20.20%22.70%-25.84%13.31%

Correlation

The correlation between WDNA and NTSX is 0.53, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.53

Correlation (3Y)
Calculated over the trailing 3-year period

0.59

Correlation (5Y)
Calculated over the trailing 5-year period

0.65

Correlation (All Time)
Calculated using the full available price history since Jun 4, 2021

0.65

The correlation between WDNA and NTSX shifts across timeframes, from 0.53 (1 year) to 0.65 (5 years), reflecting how their relationship changes across market environments.

WDNA vs. NTSX - Sectors Allocation Comparison


Sectors
WDNA
NTSX

Healthcare

85.0%
8.4%

Basic Materials

6.5%
1.4%

Consumer Defensive

3.0%
5.5%

Energy

1.1%
3.5%

Communication Services

-

12.5%

Consumer Cyclical

-

10.1%

Financial Services

-

12.3%

Industrials

-

7.7%

Real Estate

-

1.5%

Technology

-

35.1%

Utilities

-

2.1%

Healthcare

WDNA
85.0%
NTSX
8.4%

Basic Materials

WDNA
6.5%
NTSX
1.4%

Consumer Defensive

WDNA
3.0%
NTSX
5.5%

Energy

WDNA
1.1%
NTSX
3.5%

Communication Services

WDNA

-

NTSX
12.5%

Consumer Cyclical

WDNA

-

NTSX
10.1%

Financial Services

WDNA

-

NTSX
12.3%

Industrials

WDNA

-

NTSX
7.7%

Real Estate

WDNA

-

NTSX
1.5%

Technology

WDNA

-

NTSX
35.1%

Utilities

WDNA

-

NTSX
2.1%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WDNA vs. NTSX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WDNA
WDNA Risk / Return Rank: 6363
Overall Rank
WDNA Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
WDNA Sortino Ratio Rank: 6262
Sortino Ratio Rank
WDNA Omega Ratio Rank: 5353
Omega Ratio Rank
WDNA Calmar Ratio Rank: 8383
Calmar Ratio Rank
WDNA Martin Ratio Rank: 5757
Martin Ratio Rank

NTSX
NTSX Risk / Return Rank: 6363
Overall Rank
NTSX Sharpe Ratio Rank: 6464
Sharpe Ratio Rank
NTSX Sortino Ratio Rank: 6262
Sortino Ratio Rank
NTSX Omega Ratio Rank: 6363
Omega Ratio Rank
NTSX Calmar Ratio Rank: 5858
Calmar Ratio Rank
NTSX Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WDNA vs. NTSX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and WisdomTree U.S. Efficient Core Fund (NTSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WDNANTSXDifference
Sharpe ratioReturn per unit of total volatility

-0.11

Sortino ratioReturn per unit of downside risk

0.00

Omega ratioGain probability vs. loss probability

1.32

1.38

-0.05

Calmar ratioReturn relative to maximum drawdown

4.34

2.81

+1.53

Martin ratioReturn relative to average drawdown

9.85

12.44

-2.59

WDNA vs. NTSX - Sharpe Ratio Comparison

The current WDNA Sharpe Ratio is 1.98, which is comparable to the NTSX Sharpe Ratio of 2.09. The chart below compares the historical Sharpe Ratios of WDNA and NTSX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


WDNANTSXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.98

2.09

-0.11

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.19

0.58

-0.77

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.19

0.72

-0.91

Drawdowns

WDNA vs. NTSX - Drawdown Comparison

The maximum WDNA drawdown since its inception was -58.87%, which is greater than NTSX's maximum drawdown of -31.34%. Use the drawdown chart below to compare losses from any high point for WDNA and NTSX.


Loading charts...

Drawdown Indicators


WDNANTSXDifference

Max Drawdown

Largest peak-to-trough decline

-58.87%

-31.34%

-27.53%

Max Drawdown (1Y)

Largest decline over 1 year

-11.70%

-9.16%

-2.54%

Max Drawdown (3Y)

Largest decline over 3 years

-38.25%

-16.82%

-21.43%

Max Drawdown (5Y)

Largest decline over 5 years

-58.87%

-31.34%

-27.53%

Current Drawdown

Current decline from peak

-29.86%

-0.25%

-29.61%

Average Drawdown

Average peak-to-trough decline

-35.64%

-6.79%

-28.85%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.14%

2.07%

+3.07%

Volatility

WDNA vs. NTSX - Volatility Comparison

WisdomTree BioRevolution Fund (WDNA) has a higher volatility of 7.35% compared to WisdomTree U.S. Efficient Core Fund (NTSX) at 3.38%. This indicates that WDNA's price experiences larger fluctuations and is considered to be riskier than NTSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


WDNANTSXDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.35%

3.38%

+3.97%

Volatility (6M)

Calculated over the trailing 6-month period

16.59%

9.61%

+6.98%

Volatility (1Y)

Calculated over the trailing 1-year period

25.66%

12.32%

+13.34%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.08%

17.04%

+8.04%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.07%

18.27%

+6.80%

WDNA vs. NTSX - Expense Ratio Comparison

WDNA has a 0.45% expense ratio, which is higher than NTSX's 0.20% expense ratio.


Dividends

WDNA vs. NTSX - Dividend Comparison

WDNA's dividend yield for the trailing twelve months is around 4.19%, more than NTSX's 1.07% yield.


PositionTTM20252024202320222021202020192018
NTSX
WisdomTree U.S. Efficient Core Fund
1.07%1.14%1.14%1.21%1.36%0.82%0.92%1.42%0.62%
WDNA
WisdomTree BioRevolution Fund
4.19%4.57%0.75%0.80%0.38%0.10%0.00%0.00%0.00%

Frequently Asked Questions


WDNA and NTSX have a correlation of 0.53, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

WDNA has higher volatility (7.35%) compared to NTSX (3.38%). In terms of maximum drawdown, WDNA dropped -58.87% vs NTSX's -31.34%.

On 5-year performance, NTSX leads with 9.87% vs -4.78% for WDNA. On fees, NTSX is cheaper at 0.20% per year. On volatility, NTSX has been the lower-risk option at 3.38%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, NTSX has performed better with a 9.87% return vs -4.78%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

NTSX is cheaper with a 0.20% expense ratio, compared with 0.45% for WDNA.

WDNA has the higher dividend yield at 4.19%, compared with 1.07% for NTSX.

WDNA is categorized as Health & Biotech Equities, while NTSX is Diversified Portfolio. Their fees differ too: 0.45% for WDNA and 0.20% for NTSX.

NTSX currently has the higher Sharpe Ratio (2.09 vs 1.98), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for WDNA and NTSX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer